Balancing the Nanoscale Organization in Multivalent Materials for Functional Inhibition of the Programmed Death-1 Immune Checkpoint.

DNA origami PD-1 T cell activation dendritic cells immune checkpoint blockade multivalency spatial organization

Journal

ACS nano
ISSN: 1936-086X
Titre abrégé: ACS Nano
Pays: United States
ID NLM: 101313589

Informations de publication

Date de publication:
21 Dec 2023
Historique:
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

Dendritic cells (DCs) regulate immune priming by expressing programmed death ligand 1 (PD-L1) and PD-L2, which interact with the inhibitory receptor PD-1 on activated T cells. PD-1 signaling regulates T cell effector functions and limits autoimmunity. Tumor cells can hijack this pathway by overexpressing PD-L1 to suppress antitumor T cell responses. Blocking this inhibitory pathway has been beneficial for the treatment of various cancer types, although only a subset of patients responds. A deepened understanding of the spatial organization and molecular interplay between PD-1 and its ligands may inform the design of more efficacious nanotherapeutics. We visualized the natural molecular PD-L1 organization on DCs by DNA-PAINT microscopy and created a template to engineer DNA-based nanoclusters presenting PD-1 at defined valencies, distances, and patterns. These multivalent nanomaterials were examined for their cellular binding and blocking ability. Our data show that PD-1 nano-organization has profound effects on ligand interaction and that the valency of PD-1 molecules modulates the effectiveness in restoring T cell function. This work highlights the power of spatially controlled functional materials to unravel the importance of multivalent patterns in the PD-1 pathway and presents alternative design strategies for immune-engineering.

Identifiants

pubmed: 38126310
doi: 10.1021/acsnano.3c06552
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Kaltrina Paloja (K)

Programmable Biomaterials Laboratory, Institute of Materials, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.

Jorieke Weiden (J)

Programmable Biomaterials Laboratory, Institute of Materials, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.

Joschka Hellmeier (J)

Max Planck Institute of Biochemistry, Planegg 82152, Germany.

Alexandra S Eklund (AS)

Max Planck Institute of Biochemistry, Planegg 82152, Germany.

Susanne C M Reinhardt (SCM)

Max Planck Institute of Biochemistry, Planegg 82152, Germany.
Faculty of Physics and Center for Nanoscience, Ludwig Maximilian University, Munich 80539, Germany.

Ian A Parish (IA)

Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3128, Australia.

Ralf Jungmann (R)

Max Planck Institute of Biochemistry, Planegg 82152, Germany.
Faculty of Physics and Center for Nanoscience, Ludwig Maximilian University, Munich 80539, Germany.

Maartje M C Bastings (MMC)

Programmable Biomaterials Laboratory, Institute of Materials, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.
Interfaculty Bioengineering Institute, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.

Classifications MeSH